Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Nicole Carabetta"'
Autor:
Giuseppe Panuccio, Youssef S. Abdelwahed, Nicole Carabetta, Ulf Landmesser, Salvatore De Rosa, Daniele Torella
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 11, Iss 9, p 295 (2024)
Chronic total occlusions (CTOs) represent a challenging scenario in coronary artery disease (CAD). The prevalence of CTOS in patients undergoing coronary angiography underscores the need for effective diagnostic and therapeutic strategies. Coronary a
Externí odkaz:
https://doaj.org/article/2aa0185533184ca591a806b37efb844c
Autor:
Nicole Carabetta, Fabiola Boccuto, Giuseppe Panuccio, Giovanni Canino, Ciro Indolfi, Salvatore De Rosa
Publikováno v:
European Heart Journal Supplements. 24
Background The use of TAVR has been spreading out globally due to its favorable safety profile and the excellent efficacy data from randomized controlled trials. With the growing number of treated patients, the attention is rising around specific iss
Autor:
Alessandra Panarello, Sabato Sorrentino, Anna Franzone, Federica Bruno, Martina Sportelli, Nicole Carabetta, Assunta Di Costanzo, Alberto Polimeni, Domenico Angellotti, Domenico Simone Castiello, Fiorenzo Simonetti, Carmen Spaccarotella, Annalisa Mongiardo, Giovanni Esposito, Ciro Indolfi
Publikováno v:
European Heart Journal Supplements. 24
Background Transcatheter aortic valve replacement (TAVR), is the treatment of choice for most patients with aortic stenosis. Transfemoral access remains the most widely used peripheral vascular approach for TAVR and dedicated plug-based or suture-bas
Autor:
Fabiola Boccuto, Nicole Carabetta, Michele Antonio Cacia, Giuseppe Panuccio, Claudia Critelli, Ciro Indolfi, Salvatore De Rosa
Publikováno v:
European Heart Journal Supplements. 24
Introduction although transcatheter aortic valve replacement (TAVR) represents a milestone in the treatment of degenerative aortic stenosis, stroke remains an important complication compared to surgical aortic valve replacement (SAVR). Multiple magne
Autor:
Nicole Carabetta, Sabato Sorrentino, Fabiola Boccuto, Antonio Bellantoni, Salvatore Giordano, Michele Antonio Cacia, Alberto Polimeni, Isabella Leo, Ylenia Varano, Florinda Maria Augusto, Annalisa Mongiardo, Salvatore De Rosa, Ciro Indolfi, Carmen Spaccarotella
Publikováno v:
European Heart Journal Supplements. 23
Aims Post-procedural bleedings have a significant impact on mortality in patients undergoing transcatheter aortic valve replacement (TAVR). Unfortunately, the source of these bleedings is often undetermined, causing difficulties in diagnosis and rela
Autor:
Michele Antonio Cacia, Sabato Sorrentino, Isabella Leo, Alberto Polimeni, Jolanda Sabatino, Nadia Salerno, Fabiola Boccuto, Nicole Carabetta, Antonio Bellantoni, Giuseppe Panuccio, Florinda Maria Augusto, Ylenia Varano, Salvatore De Rosa, Annalisa Mongiardo, Carmen AnnaMaria Spaccarotella, Ciro Indolfi
Publikováno v:
European Heart Journal Supplements. 23
Aims A small effective orifice area (EOA) by body surface area (BSA), defined as prosthesis–patient mismatch (PPM), is associated with elevated transprosthetic pressure gradients, less ventricular remodelling, and a worse prognosis. Calculating PPM
Autor:
Salvatore Giordano, Sabato Sorrentino, Annalisa Mongiardo, Antonio Bellantoni, Fabiola Boccuto, Nicole Carabetta, Vincenzo Riverso, Cinzia Mancuso, Ciro Indolfi, Carmen Spaccarotella
Publikováno v:
European Heart Journal Supplements. 23
Aims Transcatheter implantation of a balloon-expandable aortic valve is associated with an acute stent recoil . Conversely, the acute effects of nitinol-based stent frame- self expandable valve on post-deployment dimensions have not been reported. Ac
Autor:
Fabiola Boccuto, Sabato Sorrentino, Nicole Carabetta, Antonio Bellantoni, Salvatore Giordano, Michele Antonio Cacia, Alberto Polimeni, Isabella Leo, Ylenia Varano, Florinda Maria Augusto, Annalisa Mongiardo, Salvatore De Rosa, Ciro Indolfi, Carmen Spaccarotella
Publikováno v:
European Heart Journal Supplements. 23
Aims Many efforts have been made in the last decade to minimize the risk of bleeding in patients undergoing transcatheter aortic valve replacement (TAVR), such as a less intensive antithrombotic therapy and technical improvement in devices implantati